Lobbying Filing Details

Total Spending

$30,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
57c4d2ec-757c-4eb6-8653-718c13295244
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 05, 2026 at 10:00 AM
Income:
$30,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
LMH STRATEGIC SOLUTIONS
Washington, District of Columbia
Client
IONIS PHARMACEUTICALS, INC.

Biotechnology company.

California, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.

Lobbyists (2)
  • ALANNA TEMME
  • SONIA GOH
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.